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Background: Globally, over one-third of pregnant women are 
anaemic and are at increased risk of postpartum haemorrhage (PPH).  
Tranexamic acid (TXA) given within 3 hours of birth significantly 
reduces death due to bleeding in women with PPH. However, for 
many, treatment is too late to prevent death from PPH. The WOMAN-2 
trial aims to see if giving TXA can prevent PPH and other outcomes in 
women with moderate and severe anaemia. Assessing the impact of 
postpartum blood loss on women’s own perceptions of their health 
and well-being is an important outcome for the WOMAN-2 trial. This 
study aimed to develop a conceptual framework and questionnaire to 
measure the impact of postpartum blood loss on participant-reported 
outcomes (PRO) in women with moderate and severe anaemia. 
Methods: A conceptual framework and PRO questionnaire were 
developed using a multifaceted, iterative process. Factors influencing 
anaemic women’s postpartum experience were identified from review 
of the literature and through group discussion with them.  De novo 
items were combined with those from an existing instrument (Multi-
dimensional Fatigue Symptom Inventory, Short Form (MFSI-SF)). 
Content validity was tested among a group of obstetricians and 
anaemic postpartum women, revised and then pilot tested among 124 
women with moderate and severe anaemia following vaginal birth.  
Results: Women with moderate and severe anaemia who experienced 
PPH reported more fatigue on the MFSI-SF (p=0.001); reported feeling 
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more ill (p=0.004); and had greater difficulty breastfeeding (p=0.039), 
compared to those who did not experience PPH. Compared to women 
with moderate anaemia, women with severe anaemia reported 
experiencing worse symptoms of anaemia (p=0.001) and scored worse 
on the MFSI-SF (p=0.007). 
Conclusions: Significant differences between the scores of women 
who developed PPH and those who did not and the scores between 
women with moderate and severe anaemia indicate that the 
questionnaire had satisfactory construct validity.
Keywords 
participant reported outcomes, postpartum haemorrhage, anaemia, 
questionnaire, fatigue
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Introduction
There are about 100,000 maternal deaths from postpartum 
haemorrhage (PPH) every year with most occurring in low and 
middle income countries1–4. Of the women who survive PPH, 
many suffer severe morbidity including hysterectomy which 
removes the possibility of having more children. The morbid-
ity associated with PPH can also interfere with breastfeeding and 
bonding5,6.
Despite efforts to prevent anaemia, many women give birth with 
low haemoglobin levels. Anaemia increases the risk of PPH7. 
In women with anaemia, even moderate bleeding can threaten 
their lives. Fatigue due to anaemia restricts a mother’s abil-
ity to care for her children and impacts her well-being8. There 
is an urgent need to find an effective way to reduce postpartum 
bleeding in anaemic women.
The recently published WOMAN Trial of tranexamic acid (TXA) 
in women with PPH showed that, when given within 3 hours of 
birth, death due to bleeding was reduced by about 30% with no 
adverse effects9,10. However, as most PPH deaths occur soon 
after giving birth and women with anaemia are at increased risk, 
treatment is too late to prevent death in many women. Trials of 
the prophylactic use of TXA to prevent PPH are inconclusive11, 
most have serious flaws12 and very few collected data on maternal 
well-being.
The WOMAN-2 trial aims to determine the effects of TXA 
in women with moderate or severe anaemia who give birth 
vaginally13. Results from clinical trials of TXA in elective 
surgery show that TXA treatment seems to move the entire 
distribution of bleeding towards reduced blood loss by about 
one third irrespective of baseline blood loss14. If this is also the 
case in postpartum anaemic women, then trial participants have 
the potential to benefit whether or not they experience PPH, 
since even moderate or mild blood loss can have adverse health 
consequences in anaemic women13. Therefore, assessing the 
impact of any postpartum blood loss on a woman’s own percep-
tions of her health and well-being is an important outcome for 
the WOMAN-2 trial. Including participant-reported outcomes 
(PRO) is emphasised as a core outcome for studies evaluating 
interventions for prevention of PPH15.
There are no standard measures, however, to assess the impact 
of blood loss on the health and well-being of women with vary-
ing degrees of anaemia at discharge from hospital after giving 
birth. This study aims to (1) build a conceptual framework to 
assess the impact of early postpartum blood loss on relevant PRO 
for women who give birth with moderate and severe anaemia 
and (2) develop a questionnaire to measure women’s perceptions 
of aspects of their health and well-being that would be suitable 
for use in the WOMAN-2 trial. 
Methods
An overview of the development process is provided in Figure 1.
Phase 1: Initial conceptual framework and questionnaire 
design
Step A: A review of the literature was conducted to identify 
relevant domains of health and well-being for postpartum anae-
mic women and to identify existing questionnaires. An initial 
conceptual framework and an outline set of questions were 
developed. A group consisting of new mothers from our patient 
and public involvement (PPI) group in the UK attended a face- 
to-face meeting and added to the relevant domains and provided 
feedback on the outline set of questions. The questionnaire was 
further revised based on this feedback, team discussion, addi-
tional literature review, and existing tools which measured 
domains identified as important.
Step B: A protocol for pilot testing the questionnaire was devel-
oped. To test the appropriateness of our questions, we enrolled 
Figure 1. Conceptual framework and questionnaire development process.
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anaemic women who had vaginal births with no PPH, and anae-
mic women who had vaginal births and experienced a PPH. 
Women were enrolled from the postnatal wards of one hospital 
in Rawalpindi, Pakistan. We hypothesized that if women who 
experienced a PPH or severe anaemia answered the questions 
differently than women who did not experience a PPH or had 
moderate anaemia, then the questions would be able to detect the 
required differences in the WOMAN-2 trial.
The pilot study objectives included: (1) assessing whether 
questions address outcomes and experiences relevant to anae-
mic women who have just given birth; (2) assessing whether 
questions are understood similarly by participants and research 
team; (3) assessing whether questions and answer choices are 
clearly understood by participants; (4) how to accurately translate 
questions and answer choices; and (5) assessing whether anae-
mic women with different birth experiences, such as those who 
suffered a PPH, answer questions differently compared to those 
who did not. Women were eligible for inclusion in the pilot 
study if they had moderate or severe anaemia (haemoglobin 
<10 g/dl), had given birth vaginally (up to 42 days), and had not 
yet been discharged from the hospital. During the study period, 
medical records of women who gave birth at the hospital were 
reviewed. Eligible women were invited to participate. The number 
of participants to be enrolled in this study was anticipated to 
be dynamic, depending on how women answered draft ques-
tions and what types of issues were identified during the pilot. 
Enrolment was expected to be between 30–300 women.
Ethical approval was obtained from the London School of 
Hygiene & Tropical Medicine (Ref: 15206) and Rawalpindi 
Medical University, Rawalpindi, Pakistan, prior to initiat-
ing the pilot study. Participants provided written informed 
consent to participate. We recorded research findings using the 
draft questionnaire, cognitive interview questionnaire, and a daily 
debriefing form.
Phase 2: Modification and pilot testing
Step A: An expert panel of four local obstetricians at one 
hospital in Pakistan reviewed and modified the questionnaire 
and translated it into Urdu. The questionnaire was reviewed by 
a group of women soon after they had given birth and modified, 
and then tested on individual patients over three days.
Cognitive interviews explored participant understanding of 
questions and answer choices, whether participants under-
stood the questions, whether they were able to say in their own 
words what the question was asking and any suggestions for 
improving the questions. Qualitative data were analysed at the 
end of each day and the questionnaire modified accordingly.
Step B: A final version of the questionnaire16 was developed, 
translated, and printed into Urdu and English. This was tested 
between April and July 2018 at the hospital.
Phase 3: Quantitative analysis of pilot study
Step A: Descriptive statistics were used to describe background 
characteristics of the study population. Scores for the relevant 
domains were calculated for each participant. T-tests, Z-tests, 
linear and logistic regression (Stata Statistical Software: Release 
15. College Station, TX: StataCorp LLC) were used to explore 
the data and examine the association between how women 
reported their health and well-being and a) if they experienced 
PPH and b) if they had severe anaemia. 
Step B: We examined the quantitative and qualitative results 
of the study and decided on the final conceptual framework and 
questionnaire for inclusion in the WOMAN-2 trial.
Results
Raw data for this study are available from LSHTM Data 
compass following free registration16.
Phase 1: Initial conceptual framework and questionnaire 
design
Step A: The outline set of questions sought participant reported 
perspectives on breastfeeding, symptoms of anaemia, feel-
ings, and ability to do daily activities. The new mothers PPI 
group noted the following: asking about the mother’s health 
and well-being would be welcomed, as immediately after birth 
much attention is focused on the baby, rather than the mother; 
the importance of keeping the questionnaire as short as possible; 
and that new mothers are worried about if they will be able 
to care for and feed their baby properly.
Step B: Further review of the literature identified the Multidimen-
sional Fatigue Symptom Inventory-short form (MFSI-SF)17,18, 
which was initially developed as a measure for cancer patients, 
and has been applied in different disease areas19. The MFSI-SF 
provides a composite score for multidimensional fatigue and 
includes scores for the test’s five component domains: general 
fatigue, physical fatigue, emotional fatigue, mental fatigue, and 
vigour. This measure has been shown to have good psychomet-
ric properties, has been validated, and is recommended for use in 
studies19. We chose to test this instrument because of success-
ful use in previous trials, and because it includes many of the 
domains we were interested in measuring, such as fatigue, energy 
levels, and feelings. Although the recall time and wording of the 
tool was not written for women who had recently given birth, 
the MFSI-SF was selected as an appropriate tool to adapt and 
test in this pilot study.
Phase 2: Modification and pilot testing
Step A: Key feedback on the draft questionnaire raised by the 
expert team of four local obstetricians included: women will be 
tired so questions should be kept short; many participants will 
have little education or be illiterate; and use of visual scales is 
not generally understood in this population. The overall struc-
ture of the questionnaire was kept, with slight modifications 
made to questions and answer choices. For the MFSI-SF, 
vernacular wording in the questions was first translated into more 
understandable English for international use, and then translated 
into Urdu.
Feedback froman initial group of six participants included: the 
set of questions about physical and mental abilities and feelings 
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due to fatigue were inappropriate for them because these were 
primarily affected by pain; and answer responses should be 
short, simple, and consistent across the entire questionnaire, as 
was used in the MFSI-SF section. Participants discussed their 
experiences of having anaemia. Symptoms of anaemia stated by 
participants included: breathlessness, dizziness, shaky hands, 
feeling tired, feeling faint, heart palpitations, body aches and 
pains, and numbness. Due to these symptoms, some women 
reported being worried about themselves and their ability to take 
care of their children. Questionnaire changes included removal 
of questions asking about abilities and feelings due to fatigue; 
addition of a global question on pain; addition of a global ques-
tion on wellness; addition of questions about anaemia symptoms 
for: feeling sleepy, feeling numbness, feeling of shaky hands; 
removal of all visual scales; and modification of all response 
choices to be consistent with the response choices used in the 
MFSI-SF. Important implementation factors learned at the review 
meeting were to conduct interviews in the morning, before 
hospital discharge, and to interview patients alone, with no relatives 
present.
Over three days, nine women participated in the portion of 
the pilot study which included cognitive interviews. Question-
naire administration and cognitive interviews revealed issues 
of clarity with question wording and translations. Changes to 
the questionnaire and translation were made continuously until 
participants easily understood the question meanings. For the 
MFSI-SF, it was necessary to add “since giving birth until 
now” to clarify the time period the question was referring to. 
This was because participants were not sure if the questions 
were referring to a period which included their pregnancy or 
not. Many of the questions also needed the additional clarifica-
tion of “taking into account everything…” before the question. 
This was added to help participants focus on the overall nature 
of the question. For example, some participants had compet-
ing feelings, such as feeling elated for having a first baby, but 
deeply sad and worried since their baby had been taken to the 
intensive care unit. Once this phrase was added to the ques-
tions, participants were able to understand its meaning and more 
easily answer. Table 1 provides a comparison between the 
MFSI-SF and the adapted version for this pilot study. In addi-
tion to the changes mentioned above, clear instructions with a 
simple example were added at the beginning to introduce the 
process. Interviews were best conducted in the mornings, when 
women could lay in their beds and be more comfortable for the 
duration of the interview.
Step B: The final pilot questionnaire contained six domains 
and 41 questions. The six domains included: multidimensional 
fatigue (MFSI-SF: 30 questions), symptoms of anaemia (7 ques-
tions: dizziness, headache, heart beating fast/racing, feeling 
sleepy, numbness in hands and feet, shaky feeling in hands, 
difficulty breathing), statement of feeling ill (1 question), state-
ment of feeling pain (1 question), statement about difficulty 
breastfeeding (1 question), and perception of expected ability 
to do usual activities once home (1 question). Each of the 41 
questions had the same five response choices: not at all, a little, 
moderately, quite a bit, extremely.
Phase 3: Quantitative analysis of pilot study and 
finalisation of questionnaire
Step A: Baseline characteristics of the pilot study population 
are provided in Table 2. A total of 124 women were enrolled 
in the final pilot study, ranging in age from 18–38 years. All 
participants had anaemia, with 23% having severe anaemia 
(<7 g/dl); 31.5% of the study population experienced a PPH.
Score calculations. The MFSI-SF scores were calculated as 
per instructions from the MFSI-SF tool18,20. An overall anae-
mia symptoms score was calculated by adding the scores of 
seven separate anaemia symptom questions. Illness, pain, and 
expected ability to do usual activities were single questions. 
Because many women who experienced a PPH were not able to 
breastfeed, this information was combined with the question 
about difficulty breastfeeding by adding a score “worse” than 
“extremely” on the difficulty scale for women who were not 
breastfeeding.
For analyses examining illness, pain, expected ability to do usual 
activities, and breastfeeding, responses were categorised into two 
groups: those answering “not at all”, “a little” or “moderately” 
or those answering “quite a bit” or “extremely” (with breast-
feeding having one additional “worse” score after “extremely” 
to reflect not breastfeeding).
Figure 2a, b shows there is strong evidence that participants 
who experienced PPH compared to those who didn’t experience 
PPH, and those with severe anaemia compared to those with 
moderate anaemia, answered questions on the MFSI-SF differ-
ently, with those experiencing PPH or severe anaemia having 
higher scores, indicating they felt more fatigue. Figure 2c, d 
shows there is strong evidence that participants who experi-
enced a PPH compared to those who didn’t experience a PPH, 
and those with severe anaemia compared to those with moderate 
anaemia, reported more symptoms of anaemia. Similar results 
examining the same relationships, via multiple linear regression, 
are reported in Table 3.
Adjusted analyses of subdomains within the MFSI-SF showed 
strong evidence that participants with PPH and participants 
with severe anaemia scored “worse” on different measures for 
fatigue ((general, physical, emotional, mental (severe anaemia 
only)) and vigour (PPH only) (Table 3).
The pilot study results indicate that participants who experi-
enced a PPH, when adjusted for severe anaemia, reported feel-
ing more ill than participants without PPH (Table 3). When 
considering reported difficulty breastfeeding together with 
not breastfeeding, women who experienced a PPH, when 
taking into account severe anaemia, reported more difficulty or 
“inability” to breastfeed.
In this analysis, there was no evidence of an association between 
reporting pain and experiencing PPH or severe anaemia (Table 3). 
There was also no evidence of an association between report-
ing an expectation of difficulty of doing usual activities when 
going home and experiencing PPH or severe anaemia (Table 3).
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MFSI-SF MFSI-SF Adapted for Woman-2 Pilot
Below is a list of statements that 
describe how people sometimes 
feel. Please read each item 
carefully, then circle the one 
number next to each item which 
best describes how true each 
statement has been for you in 
the past 7 days.
I am going to read some statements to you that describe how people sometimes 
feel. Each question has five possible answers. Please tell me which answer best 
describes how you feel since having your baby until now. 
 
I will give you an example: 
I will say “I feel hungry right now” and I want you to tell me which of the following 
answers best describes how hungry you feel right now. The options are not at all, 
a little, moderately, quite a bit, extremely. 
 
What answer would you give? (allow the patient to answer)
1. I have trouble remembering things Since giving birth until now I have trouble remembering things
2. My muscles ache Since giving birth until now, my muscles ache all over my body
3. I feel upset Taking into account everything since giving birth until now, I feel upset
4. My legs feel weak Since giving birth until now, my legs feel weak
5. I feel cheerful Taking into account everything since giving birth until now, I feel happy (cheerful)
6. My head feels heavy Since giving birth until now, my head feels heavy
7. I feel lively Taking into account everything since giving birth until now, I feel happy to do things 
with energy (feel lively)
8. I feel nervous Taking into account everything since giving birth until now, I feel nervous or uneasy
9. I feel relaxed Taking into account everything since giving birth until now, I feel relaxed
10. I feel pooped Since giving birth until now, I feel too tired to continue (I feel pooped)
11. I am confused Since giving birth until now, I am confused or I have difficulty understanding things
12. I am worn out Since giving birth until now, I am drained of energy (I am worn out)
13. I feel sad Taking into account everything since giving birth until now, I feel sad
14. I feel fatigued Since giving birth until now, I feel physically and mentally tired (fatigued)
15. I have trouble paying attention Taking into account everything since giving birth until now, my mind is wandering 
around (I have trouble paying attention)
16. My arms feel weak Since giving birth until now, my arms feel weak
17. I feel sluggish Since giving birth until now, I feel physically slow (sluggish)
18. I feel run down Since giving birth until now, I feel in a bad state (I feel run down)
19. I ache all over Since giving birth until now, I ache all over
20. I am unable to concentrate Taking into account everything since giving birth until now, I have trouble focussing on 
things (I am unable to concentrate)
21. I feel depressed Taking into account everything since giving birth until now, I feel depressed
22. I feel refreshed Taking into account everything since giving birth until now, I feel refreshed or fresh
23. I feel tense Taking into account everything since giving birth until now, I feel tense
24. I feel energetic Since giving birth until now, I feel energetic or have energy to do things
25. I make more mistakes than usual Since giving birth until now, I make more mistakes than usual
26. My body feels heavy all over Since giving birth until now, my body feels heavy all over
27. I am forgetful Since giving birth until now, I am forgetful
28. I feel tired Since giving birth until now, I feel physically tired
29. I feel calm Taking into account everything since giving birth until now, my mind is at peace (I feel 
calm)
30. I am distressed Taking into account everything since giving birth until now, I am as very worried 
(distressed)
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Step B: A final analysis included consideration of the quali-
tative and quantitative results, pilot study implementer feed-
back, and objectives of the questionnaire in relation to the 
WOMAN-2 Trial. It was decided that the final pilot version of 
the conceptual framework (Figure 3) and the final version of the 
questionnaire were suitable for assessing health and well-being 
outcomes in the WOMAN-2 trial.
Discussion
The purpose of this study was to develop a conceptual frame-
work and PRO questionnaire to measure maternal health and 
well-being outcomes for the WOMAN-2 trial. Our conceptual 
framework and questionnaire were developed through literature 
reviews, expert consultation, PPI consultation, and an iterative 
process of pilot testing questions with anaemic women in 
Pakistan who had just given vaginal birth and experienced different 
birth outcomes.
Limitations
A limitation of this study is that we pilot tested the question-
naire at one hospital in Pakistan, while the clinical trial will be 
carried out in multiple hospitals in Pakistan, Nigeria and Uganda. 
The hospital where the pilot was conducted draws from a popu-
lation that may be more urban and affluent than other areas 
where the trial will be conducted. Due to the pragmatic nature of 
the pilot study, we enrolled 124 participants and were only able 
to translate and test the questionnaire in Urdu. The questionnaire 
for the clinical trial will ideally need to be tested and translated 
for use in other countries and other languages.
Multifaceted and iterative process
We used a multifaceted and iterative approach to develop our con-
ceptual framework and PRO questionnaire. We consulted new 
mothers about their concerns after giving birth, and what meas-
ures would be important to include in assessing maternal health 
and well-being. We also consulted topic experts. Through our 
pilot study we modified questions and response choices until 
they were simple, clear, and easily understood by respondents. 
Language was an important factor for consideration, as different 
individuals can assign different meaning to the same words. We 
used the committee method of translation, rather than forward 
and backward translation, to ensure that the whole team agreed 
Table 2. Study population characteristics.
Description of pilot study population
Number of participants 124
Characteristics at baseline N (%)
Mean age (range) 27 (18–38)
Education level: some secondary education or above, n (%) 57 (46.3)
Median parity (range) 2 (1–8)
Birth canal trauma, n (%) 4 (3.2)
Uterine rupture, n 0
Post-partum haemorrhage, n (%) 39 (31.5)
Severe anaemia, n (%) 28 (22.6)
Laparotomy, n 0
Manual removal of placenta, n 0
Evacuation of retained products of conception, n (%) 39 (31.5)
Of women having ERPC, those also having PPH, n (%) 33 (26.6)
Transfusion (blood product), n (%) 44 (35.5)
Hysterectomy, n 0
Cardiovascular dysfunction, n 0
Respiratory dysfunction, n (%) 1 (0.8)
Renal dysfunction, n (%) 2 (1.6)
Coagulation/dysfunction, n (%) 4 (3.2)
Hepatic dysfunction, n (%) 1 (0.8)
Neurological dysfunction, n 0
Sepsis, n (%) 10 (8.1)
Post-partum eclampsia, n (%) 1 (0.8)
Baby died at this birth, n (%) 23 (18.6)
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Table 3. Association of PPH and severe anaemia on pilot questionnaire domains.
Association of PPH and severe anaemia on pilot questionnaire domains
Association of PPH and severe anaemia on MFSI total score*
Crude coefficient 95 %CI P value Adjusted 
coefficient
95 %CI P value
PPH vs. no PPH 27.88 17.85-37.91 0.000 19.88 8.55-31.21 0.001
Severe anaemia vs. moderate anaemia 28.72 17.40-40.05 0.000 17.54 4.96-30.12 0.007
Association of PPH and severe anaemia on general domain score within MFSI*
PPH vs. no PPH 7.04 4.19-9.89 0.000 4.91 1.67-8.14 0.003
Severe anaemia vs. moderate anaemia 7.45 4.25-10.64 0.000 4.69 1.10-8.28 0.011
Association of PPH and severe anaemia on physical domain score within MFSI*
PPH vs. no PPH 5.52 2.68-8.36 0.000 3.90 0.64-7.16 0.019
Severe anaemia vs. moderate anaemia 5.73 2.56 8.91 0.001 3.54 −0.080-7.16 0.055
Association of PPH and severe anaemia on emotional domain score within MFSI*
PPH vs. no PPH 6.45 4.25-8.65 0.000 4.81 2.32-7.31 0.000
Severe anaemia vs. moderate anaemia 6.29 3.77-8.81 0.000 3.58 0.81- 6.36 0.012
Association of PPH and severe anaemia on mental domain score within MFSI*
PPH vs. no PPH 3.11 1.02-5.20 0.004 1.30 −1.05-3.65 0.275
Severe anaemia vs. moderate anaemia 4.69 2.44-6.95 0.000 3.96 1.35-6.57 0.003 
Association of PPH and severe anaemia on vigour domain score within MFSI*#
PPH vs. no PPH -5.76 −7.62-−3.91 0.000 -4.96 −7.10-−2.81 0.000
Severe anaemia vs. moderate anaemia -4.56 −6.77-−2.35 0.000 -1.77 −4.15-0.61 0.143
Figure 2. Multi-dimensional Fatigue Symptom Inventory, Short Form (MFSI-SF) and anaemia scores by postpartum haemorrhage and 
severe anaemia. PPH, postpartum haemorrhage.
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Association of PPH and severe anaemia on pilot questionnaire domains
Association of PPH and severe anaemia on MFSI total score*
Crude coefficient 95 %CI P value Adjusted 
coefficient
95 %CI P value
Association of PPH and severe anaemia on anaemia symptoms score*
PPH vs. no PPH 4.02 1.52-6.51 0.002 1.67 −1.11- 4.45 0.236
Severe anaemia vs. moderate anaemia 6.08 3.41-8.74 0.000 5.14 2.05-8.22 0.001
Association of PPH and severe anaemia on whether women answered “quite a bit or extremely” vs. “not at all, a little, 
moderately” regarding having pain right now+
PPH vs. no PPH 1.75 0.56-5.44 0.334 2.18 0.60-7.92 0.236
Severe anaemia vs. moderate anaemia 0.93 0.254-3.58 0.913 0.60 0.13-2.78 0.510
Association of PPH and severe anaemia on whether women answered “quite a bit or extremely” vs. “not at all, a little, 
moderately” regarding feeling ill right now+
PPH vs. no PPH 6.39 2.62-15.59 0.000 4.39 1.61-11.98 0.004
Severe anaemia vs. moderate anaemia 5.00 2.00-12.48 0.001 2.38 0.82-6.87 0.109
Association of PPH and severe anaemia on whether women answered “quite a bit or extremely” vs. “not at all, a little, 
moderately” regarding whether they think they will have difficulty doing their usual activities after returning home+
PPH vs. no PPH 2.18 0.96-5.00 0.062 1.70 0.67-4.29 0.260
Severe anaemia vs. moderate anaemia 2.42 0.94-6.25 0.068 1.82 0.62-5.30 0.273
Association of PPH and severe anaemia on whether women answered “quite a bit or extremely” (or were not breast 
feeding) vs. “not at all, a little, moderately” regarding having difficulty breastfeeding my baby+
PPH vs. no PPH 3.45 1.57-7.61 0.002 2.58 1.05-6.33 0.039
Severe anaemia vs. moderate anaemia 3.24 1.36- 7.74 0.008 1.96 0.72-5.33 0.186
* Effect estimates are calculated using linear regression
# Lower scores denote being better off (opposite direction of other domains within MFSI)
+ Effect estimates are calculated using logistic regression
Figure 3. Conceptual framework.
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translations were accurate and would be understood in the same 
way in both English and Urdu. Results of our four-month pilot 
study with 124 participants showed that the questionnaire was 
easily understood by participants and had a 20-minute imple-
mentation time. These features are important for our population 
who are likely to be within hours or a few days of giving birth, 
and are therefore tired and in pain, with attention focused on 
their babies. Based on these findings, we believe the final ques-
tionnaire piloted in this study is acceptable and relevant to 
mothers, and feasible to implement in busy maternity wards.
Quantitative results
We examined the association between how women reported 
their health and well-being in six different domains and if they 
had experienced a PPH or severe anaemia.
MFSI, anaemia, feeling ill, breastfeeding. We found that women 
who experienced a PPH or had severe anaemia were more likely 
to report poorer outcomes with respect to the total MFSI-SF 
score, indicating that those women experienced statistically 
significant more fatigue. Although we did make modifications 
to the recall time and wording of the validated tool, the 
questionnaire performed well for our purposes and was sensi-
tive enough to detect differences in multidimensional fatigue 
in our population. As expected, women who had severe anae-
mia reported more severe symptoms of anaemia compared to 
women with moderate anaemia. This demonstrates that our set of 
questions are able to detect differences in symptoms which 
are important to women. Our results showed that women who 
experienced a PPH or were severely anaemic were more likely 
to report feeling ill. In our study, 39 women experienced a PPH, 
of which 23 were not breastfeeding at the time of the question-
naire. For our analysis examining the associations of PPH 
and severe anaemia on breastfeeding, we chose to combine 
the two most difficult levels of breastfeeding with not breastfeed-
ing to more accurately reflect the effect a PPH or severe anaemia 
might have on a woman’s ability to breastfeed. Based on results 
of this pilot study, for the WOMAN-2 trial, we will include an 
additional question about why the participant is not breastfeed-
ing, so we can exclude women who have specific reasons why 
they are not breastfeeding which are unrelated to the effects of 
PPH or anaemia. 
Pain, expected ability to do usual activities once home. Based 
on discussions with participants, we understood that pain was 
a symptom which was affecting their well-being immedi-
ately after childbirth. Our results did not show that women who 
experienced a PPH or had severe anaemia reported more pain. 
This may be because pain is common across all postpartum 
women and may not be affected by PPH or anaemia. We decided 
to keep this question in the final questionnaire for the clinical 
trial because this outcome was identified as important to partici-
pants and may impact physical abilities such as walking which 
is being assessed in the trial. Our question about expected dif-
ficulty to do usual activities once home also did not show 
that women who experienced PPH or severe anaemia answered 
that question differently than women who did not experi-
ence PPH or had moderate anaemia. This result could be 
because the effects of a PPH or severe anaemia were not such to 
warrant women stating they expected more difficulty to do their 
usual activities. Alternatively, this result might be due to specific 
cultural circumstances: families in the area of our pilot study 
typically expect a postpartum woman to rest, while female 
family members take care of chores. This cultural practice may 
not be the case in other populations where the WOMAN-2 trial 
will be conducted, or where populations are less affluent. Another 
possible explanation is that this question, unlike other questions, 
asks a woman to anticipate her future situation. Women may 
answer this question based on their hopes, rather than on their 
realities or their fears. For these reasons and because women 
shared with us their concerns about being able to take care of their 
children, we chose to keep this question in the final questionnaire 
for the WOMAN-2 trial.
Conclusion
We have developed a conceptual framework and PRO ques-
tionnaire to measure how blood loss affects anaemic women’s 
health and well-being. Our iterative and multi-faceted approach, 
using qualitative and quantitative methods, has allowed us to 
develop a questionnaire which measures health and well-being 
outcomes important to mothers, which is clear and acceptable 
to women in the immediate postpartum period, and which has 
demonstrated sensitivity with respect to detecting differences 
in how women who experience PPH or severe anaemia answer 
questions. The final conceptual framework and questionnaire 
used in our pilot study will be included in the WOMAN-2 trial 
to be conducted in Pakistan, Nigeria, and Uganda.
Data availability
Underlying data
The anonymised data used for the quantitative analysis is available 
from the freeBIRD data portal at https://freebird.lshtm.ac.uk/index.
php/data-sharing/downloads/woman-2-pilot-study/ following free 
registration: DOI https://doi.org/10.17037/DATA.0000110916.
Extended data
The full questionnaire generated for the study is available from 
the freeBIRD data portal at https://freebird.lshtm.ac.uk/index.
php/data-sharing/downloads/woman-2-pilot-study/. following free 
registration: DOI https://doi.org/10.17037/DATA.0000110916.
Data are available under the terms of an Open Data Commons 
Attribution License (ODC-By) licence.
Grant information
This study was funded by the Wellcome Trust (grant 208870) 
and the Bill & Melinda Gates Foundation (grant OPP1176150). 
Women were not paid for taking part. 
The funders had no role in study design, data collection and 
analysis, decision to publish, or preparation of the manuscript.
Page 10 of 16
Wellcome Open Research 2019, 4:85 Last updated: 03 JUN 2021
References
1. Calvert C, Thomas SL, Ronsmans C, et al.: Identifying regional variation in 
the prevalence of postpartum haemorrhage: a systematic review and meta-
analysis. PLoS One. 2012; 7(7): e41114.  
PubMed Abstract | Publisher Full Text | Free Full Text 
2. Carroli G, Cuesta C, Abalos E, et al.: Epidemiology of postpartum haemorrhage: 
a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008; 22(6): 999–1012. 
PubMed Abstract | Publisher Full Text 
3. The World Bank: Trends in Maternal Mortality: 1990 to 2010 WHO, UNICEF, 
UNFPA and The World Bank Estimates. World Health Organization; Geneva: 
2012. 2012; ISBN 978 92 4 150363 1.  
Reference Source
4. Say L, Pattinson RC, Gülmezoglu AM: WHO systematic review of maternal 
morbidity and mortality: the prevalence of severe acute maternal morbidity 
(near miss). Reprod Health. 2004; 1(1): 3.  
PubMed Abstract | Publisher Full Text | Free Full Text 
5. Thompson JF, Heal LJ, Roberts CL, et al.: Women’s breastfeeding experiences 
following a significant primary postpartum haemorrhage: A multicentre cohort 
study. Int Breastfeed J. 2010; 5: 5.  
PubMed Abstract | Publisher Full Text | Free Full Text 
6. Ricbourg A, Gosme C, Gayat E, et al.: Emotional impact of severe post-partum 
haemorrhage on women and their partners: an observational, case-matched, 
prospective, single-centre pilot study. Eur J Obstet Gynecol Reprod Biol. 2015; 
193: 140–143.  
PubMed Abstract | Publisher Full Text 
7. Sheldon WR, Blum J, Vogel JP, et al.: Postpartum haemorrhage management, 
risks, and maternal outcomes: findings from the World Health Organization 
Multicountry Survey on Maternal and Newborn Health. BJOG. 2014; 121 
Suppl 1: 5–13.  
PubMed Abstract | Publisher Full Text 
8. Geller SE, Adams MG, Kelly PJ, et al.: Postpartum hemorrhage in resource-poor 
settings. Int J Gynecol Obstet. 2006; 92(3): 202–211.  
PubMed Abstract | Publisher Full Text 
9. WOMAN Trial Collaborators: Effect of early tranexamic acid administration on 
mortality, hysterectomy, and other morbidities in women with post-partum 
haemorrhage (WOMAN): an international, randomised, double-blind, placebo-
controlled trial. Lancet. 2017; 389(10084): 2105–2116.  
PubMed Abstract | Publisher Full Text | Free Full Text 
10. World Health Organization (WHO): Updated WHO Recommendation on 
Tranexamic Acid for the Treatment of Postpartum Haemorrhage. Geneva; 2017. 
Reference Source
11. Sentilhes L, Winer N, Azria E, et al.: Tranexamic Acid for the Prevention of Blood 
Loss after Vaginal Delivery. N Engl J Med. 2018; 379(8): 731–742.  
PubMed Abstract | Publisher Full Text 
12. Ker K, Shakur H, Roberts I: Does tranexamic acid prevent postpartum 
haemorrhage? A systematic review of randomised controlled trials. BJOG. 
2016; 123(11): 1745–1752.  
PubMed Abstract | Publisher Full Text 
13. Ker K, Roberts I, Chaudhri R, et al.: Tranexamic acid for the prevention 
of postpartum bleeding in women with anaemia: study protocol for an 
international, randomised, double-blind, placebo-controlled trial. Trials. 2018; 
19(1): 712.  
PubMed Abstract | Publisher Full Text | Free Full Text 
14. Ker K, Prieto-Merino D, Roberts I: Systematic review, meta-analysis and meta-
regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 
2013; 100(10): 1271–1279.  
PubMed Abstract | Publisher Full Text 
15. Meher S, Cuthbert A, Kirkham JJ, et al.: Core outcome sets for prevention and 
treatment of postpartum haemorrhage: an international Delphi consensus 
study. BJOG. 2019; 126(1): 83–93.  
PubMed Abstract | Publisher Full Text 
16. Miller L, Chaudhri S, Beaumont D, et al.: WOMAN-2 Pilot Study Data. [Data 
Collection]. London School of Hygiene & Tropical Medicine, London, United 
Kingdom. 2019.  
Reference Source
17. Stein KD, Martin SG, Hann DM, et al.: A multidimensional measure of fatigue for 
use with cancer patients. Cancer Pract. 1998; 6(3): 143–152.  
PubMed Abstract | Publisher Full Text 
18. Stein KD, Jacobsen PB, Blanchard CM, et al.: Further validation of the 
multidimensional fatigue symptom inventory-short form. J Pain Symptom 
Manage. 2004; 27(1): 14–23.  
PubMed Abstract | Publisher Full Text | Free Full Text 
19. Donovan KA, Stein KD, Lee M, et al.: Systematic review of the multidimensional 
fatigue symptom inventory-short form. Support Care Cancer. 2015; 23(1): 
191–212.  
PubMed Abstract | Publisher Full Text 
20. Kevin Stein PD, Jacobsen PB: INFORMATION ABOUT THE FATIGUE SYMPTOM 
INVENTORY (FSI) AND THE MULTIDIMENSIONAL FATIGUE SYMPTOM 
INVENTORY (MFSI) Measurement of fatigue in cancer patients: Further 
validation of the Fatigue Symptom Inventory. Qual Life Res. 1998; 7: 301–310. 
Reference Source
Page 11 of 16
Wellcome Open Research 2019, 4:85 Last updated: 03 JUN 2021
Open Peer Review
Current Peer Review Status:   
Version 1
Reviewer Report 29 July 2019
https://doi.org/10.21956/wellcomeopenres.16640.r35899
© 2019 Vogel J. This is an open access peer review report distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Joshua P. Vogel  
Maternal and Child Health Program, Burnet Institute, Melbourne, Australia 
Authors aimed to develop a tool for measuring women's perceptions of health impacts of 
postpartum blood loss. They have conducted a literature review, qualitative research and pilot 
testing with postpartum women with anaemia in Pakistan (interviews and questionnaire 
completion) to develop this tool. They describe multiple cycles of consultation and tool 
development with a patient and public involvement group in the UK, obstetricians and women in 
Pakistan. The tool will be used to assess patient's perspectives in a forthcoming trial of tranexamic 
acid for PPH prevention in high-risk women (women with anaemia). 
 
Findings highlight that there are key differences in how participants reported their health and 
well-being when they had experienced a PPH or severe anaemia, highlighting the need for a tool 
specific to this population. It is to my knowledge novel and a useful piece of research to 
understanding and measuring women's experiences around blood loss, particularly for women 
with anaemia which is prevalent in many countries.  
 
Major comments:
The authors acknowledge that use of the tool in other countries/languages in the WOMAN 
trial will ideally require further evaluation. Given the domains of the tool itself, one would 
reasonably expect that concepts such as pain, activities of daily living and feeling ill would 
vary between settings. However, the concluding section indicates the tool will be used as it 
is in the other countries - clarification on whether further evaluation/adaptation is going to 
be done or not would be helpful. 
 
○
Tool was translated into Urdu, however no mention is made of back-translation/verification. 
Would be helpful to know how translation was verified.  
 
○




Under Phase 2: modification and pilot testing - change "Feedback froman initial group" to ○
 
Page 12 of 16
Wellcome Open Research 2019, 4:85 Last updated: 03 JUN 2021
"from an"
 
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use 
by others?
Yes
If any results are presented, are all the source data underlying the results available to 
ensure full reproducibility?
Yes
Are the conclusions about the method and its performance adequately supported by the 
findings presented in the article?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Maternal and perinatal health research.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard.
Reviewer Report 03 June 2019
https://doi.org/10.21956/wellcomeopenres.16640.r35608
© 2019 Meher S. This is an open access peer review report distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Shireen Meher  
1 Department of Women's and Children's Health, University of Liverpool, Liverpool, UK 
2 Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK 
3 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK 
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the participant reported outcome of maternal health and well-being in the context of PPH in 
anaemic women for the WOMAN-2 trial. This was developed through literature reviews, expert 
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I am unclear as to why the authors chose to remove questions about abilities and feelings 
due to fatigue instead of modifying them to make them more acceptable questions. My 
worry is that the acceptability of these questions may have also been influenced by cultural 
practices/beliefs.
5. 
Definition of severe anemia needs to be moved to earlier in methods and not be first 
presented in the results.
6. 
B. Conclusions - the authors state the questionnaire is acceptable to women - what this formally 
assessed i.e, were women asked this question? If not, then perhaps this statement should be 
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Comment: How were domains developed/defined? 
 
Response: We have updated the manuscript and added more details to explain our iterative 
process which explored domains of health and well-being that were stated in the literature, 
were important to new mothers, and that we could measure using a PRO tool appropriate 
for administration just after women have given birth. 
 
Comment:  What was the purpose of the additional literature review and why was it 
needed when an initial literature review had been done previously? 
 
Response: The development process of the PRO was iterative. We have added more text to 
explain this and that there was an initial review of the literature to identify relevant domains 
of health and well-being for postpartum anaemic women and to identify existing 
questionnaires, and that a further search was conducted after receiving feedback from the 
new mothers group. 
 
Comment: Who was in the team for team discussions and which experts in what field 
were consulted? 
 
Response: The team consisted of a clinical trialist/nurse, an obstetrician with qualitative 
research experience and four senior experienced obstetricians. 
 
Comment: Eligibility criteria states women had to be anaemic and within 42 days of 
delivery. Please clarify: 
- What was the time gap between blood test to confirm anaemia and date of 
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interview, as women may have been on iron tablets to correct the anaemia and if 
there was a long gap this may impact results. 
- 42 days is a long time, and it would be helpful to add further information on how 
many days postnatal the women who were interviewed actually were as this will 
impact on recall. 
 
Response: We asked for the haemoglobin level or packed cell volume prior to delivery 
recorded at this hospital admission. If that was not available, we accepted any pre-delivery 
value that was most recent prior to giving birth on this occasion. However, in all cases, the 
Hb value immediately prior to giving birth was available. 
 
A time frame of 42 days was chosen as this is traditionally considered to be the postpartum 
period. However, as all interviews took place prior to discharge after giving birth, the time 
gap was typically within 24 hours of giving birth. It is unlikely that any treatment with iron 
tablets in this short period could influence the results.  
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